Register Login
Register to leave comments
  • News bot March 12, 2026, 8:09 p.m.

    📋 INOVIO PHARMACEUTICALS, INC. (INO) - Financial Results

    Filing Date: 2026-03-12

    Accepted: 2026-03-12 16:07:16

    Event Type: Financial Results

    Event Details:

    INOVIO PHARMACEUTICALS, INC. (INO) Reports the reporting period Financial Results INOVIO PHARMACEUTICALS, INC. (INO) announced its financial results for the period ending the reporting period. Key Financial Highlights:
    • Revenue: $65,343
    • Net Income: $3
    • EPS: Not disclosed
    • Cash and equivalents: $44,273,319
      • Biologics License Application (BLA) for INO
      • 3107 accepted for review under the Accelerated Approval Program as a potential treatment for adults with Recurrent Respiratory Papillomatosis (RRP) by the U.S. Food and Drug Administration (FDA); target Prescription Drug User Fee Act (PDUFA) date October 30, 2026
      • 3107 immunological and long

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2025 2024 Change ($) Change (%)
    Current Assets Operating Lease Right Of Use Assets 6.54M 8.11M $-1.57M -19.36%
    Current Assets Other Assets 2.01M 1.98M $32.82K +1.66%
    Current Liabilities Operating Lease Liabilities 2.82M 2.50M $325.26K +13.02%
    Operating Expenses Loss From Operations -86.82M -112.40M $25.58M +22.76%
    Other Income Expense Interest Income 2.42M 4.77M $-2.35M -49.23%
    Other Income Expense Interest Expense -177.83K -177.83K $0.00 +0.00%
    Other Income Expense Net Loss 84.95M 107.25M $-22.31M -20.80%
    Prepaid Expenses and Other Current Assets 2.61M 3.72M $-1.11M -29.75%
    Other Assets 2.01M 1.98M $32.82K +1.66%
    Accounts Payable 11.05M 16.20M $-5.15M -31.77%
    Revenue 65.34K 217.76K $-152.41K -69.99%
    Loss from Operations -86.82M -112.40M $25.58M +22.76%
    Interest Income 2.42M 4.77M $-2.35M -49.23%
    Interest Expense -177.83K -177.83K $0.00 +0.00%
    Net Loss 84.95M 107.25M $-22.31M -20.80%

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: INOVIO PHARMACEUTICALS, INC.
    • Ticker Symbol: INO

Search

News categories